Speaking to Pathology in Practice at the IBMS Biomedical Science Congress in September, Beckman Coulter’s new marketing manager Leanne Annereau explained how the integration of Olympus Diagnostics is progressing.
Today’s economic realities are giving new impetus to the trend towards hospital laboratory consolidation, with many laboratory leaders implementing Lean organisational changes in the drive for greater efficiency in the face of escalating costs and workflow demands.
To remain competitive, companies must develop innovative solutions. Recent global research into how Beckman Coulter is perceived listed four key attributes that people said were the company’s strengths: integrity, collaboration, a focus on exclusively serving laboratories, and its ability to deliver practical innovation. The recent acquisition of Olympus Diagnostics is yet another example of that continuous innovation, providing the ‘perfect marriage’ for the UK’s clinical diagnostics market.
The integration of the Olympus product range into Beckman Coulter complements its current capabilities, leading to an unparalleled portfolio of core laboratory solutions. There are no gaps in the company’s offerings and it is able to serve the needs of laboratories of all sizes.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.